CD4 and neoplasm: In accordance with this NK-like phenotype and as previously reported [39]–[44], CD8α+ and DN iNKT cells displayed more potent cytotoxicity than CD4+ iNKT cells against a number of CD1d+ tumor cell lines, with consistently higher proportions expressing cell-surface CD107a and killing target cells.